1. Home
  2. LMAT vs RCKT Comparison

LMAT vs RCKT Comparison

Compare LMAT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$84.90

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.21

Market Cap

340.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
RCKT
Founded
1983
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
340.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LMAT
RCKT
Price
$84.90
$3.21
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$101.83
$29.12
AVG Volume (30 Days)
197.8K
2.0M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
0.94%
N/A
EPS Growth
27.40
N/A
EPS
2.32
N/A
Revenue
$240,866,000.00
N/A
Revenue This Year
$15.17
N/A
Revenue Next Year
$9.07
N/A
P/E Ratio
$36.76
N/A
Revenue Growth
13.07
N/A
52 Week Low
$71.42
$2.19
52 Week High
$105.55
$13.35

Technical Indicators

Market Signals
Indicator
LMAT
RCKT
Relative Strength Index (RSI) 49.86 46.08
Support Level $82.52 $3.30
Resistance Level $87.09 $3.57
Average True Range (ATR) 2.40 0.18
MACD 0.29 -0.01
Stochastic Oscillator 60.11 22.81

Price Performance

Historical Comparison
LMAT
RCKT

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: